Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 8
Drug resistance rates of Escherichia coli from 2017 to 2019.
| | 2017 | 2018 | 2019 | Escherichia coli | Drugs | Drug resistance rate (%) | Drugs | Drug resistance rate (%) | Drugs | Drug resistance rate (%) |
| | Trimethoprim | 100 | Ampicillin-sulbactam | 71.3 | Ampicillin-sulbactam | 76.8 | | Minocycline | 100 | Ciprofloxacin | 60.4 | Cefuroxime | 54.3 | | Cefazolin | 90.27 | Levofloxacin | 55.9 | Ciprofloxacin | 54.1 | | Ampicillin | 87.7 | Ceftriaxone | 55.2 | Levofloxacin | 49.9 | | Ceftriaxone | 78 | Cotrimoxazole | 49.5 | Ceftriaxone | 48.3 | | Ciprofloxacin | 78 | Gentamicin | 39.6 | Cotrimoxazole | 45.3 | | Levofloxacin | 73.2 | Aztreonam | 36.5 | Gentamicin | 34.9 | | Ampicillin-sulbactam | 65.9 | Ceftazidime | 26.4 | Aztreonam | 27.9 | | Compound sulfadiazine | 64 | Cefepime | 23.3 | Ceftazidime | 20.3 | | Aztreonam | 55.2 | Tobramycin | 14.3 | Cefepime | 17.4 | | Piperacillin | 50 | Cefoperazone-sulbactam | 7.9 | Tobramycin | 10.5 | | Tobramycin | 49.2 | Fosfomycin | 7 | Fosfomycin | 7.0 | | Cefepime | 36.4 | Ertapenem | 5.2 | Cefoperazone-sulbactam | 3.4 | | Gentamicin | 36.3 | Piperacillin-tazobactam | 4.6 | Nitrofurantoin | 2.5 | | Cefotaxime | 32.4 | Imipenem | 4 | Piperacillin-tazobactam | 2.4 | | Ceftazidime | 32 | Nitrofurantoin | 2.9 | Amikacin | 1.7 | | | | Amikacin | 1.4 | Ertapenem | 0.7 | | | | | | Imipenem | 0.6 |
|
|